Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Auris Medical completes enrollment in AM-111 trial

April 24, 2012

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Feb. 24, 2012

Pergamum begins phase II DPK-060 trial in outer ear infections

Jan. 17, 2012

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Jan. 12, 2012

Phage Pharmaceuticals submits IND for first-in-class therapeutic

Dec. 27, 2011

Second milestone reached in GenVec/Novartis collaboration

Dec. 7, 2011

Peptide P-13 ameliorates experimental otitis media

July 14, 2011

Sanofi and Audion Therapeutics to develop treatments for hearing loss

June 17, 2011

Sound Pharmaceuticals begins trial of SPI-1005 for hearing loss induced by loud music

June 8, 2011

Otonomy reports encouraging phase Ib data on OTO-104 in Meniere's disease

May 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...